Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.

NCT06086340 · clinicaltrials.gov ↗

COMPLETED

Status

779

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Palbociclib
DRUG: Aromatase Inhibitor

Sponsor

Pfizer